To our current knowledge, the COVID-19 is initiated as the viral-ACE2, the dominant host receptor interaction, and the subsequent effects on RAAS signaling, immune system, endothelium, and thrombosis confer to the complex pathologies in the viral infection. This evidence concerns the gene ACE2 and COVID-19.